FDA tentatively OKs Amneal’s generic Otezla

The FDA tentatively approves Amneal Pharmaceuticals’ (AMRX -3.5%) marketing application for a generic version of Celgene’s (CELG -0.5%) psoriasis med Otezla (apremilast).

Tentative approval means that the application met the criteria for approval but patent issues need to be resolved before the agency grants full approval.

https://seekingalpha.com/news/3479381-fda-tentatively-oks-amneals-generic-otezla